Share
Market Research Report

RESPIRATORY VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Vaccine TypeViral Vaccines · Bacterial Vaccines · Combination Vaccines
  • By InfectionInfluenza · COVID-19 · Respiratory Syncytial Virus (RSV) · Pneumonia · Tuberculosis · Others
  • By Age GroupPediatric · Adult · Geriatric
  • By Route of AdministrationIntramuscular · Intranasal · Others
  • By End UserHospitals · Clinics · Vaccination Centers · Government and Public Health Organizations · Research Institutes · Others
  • By Distribution ChannelHospital and Retail Pharmacies · Government Suppliers · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In01 Oct 2026
  • Report CodeCMI10180
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Respiratory Vaccines Market, By Vaccine Type
    • Global Respiratory Vaccines Market, By Infection
    • Global Respiratory Vaccines Market, By Age Group
    • Global Respiratory Vaccines Market, By Route of Administration
    • Global Respiratory Vaccines Market, By End User
    • Global Respiratory Vaccines Market, By Distribution Channel
    • Global Respiratory Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Manufacturing Launches/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Market Opportunities
  • Industry Trends

4. Global Respiratory Vaccines Market, By Vaccine Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Viral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Bacterial Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Combination Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Respiratory Vaccines Market, By Infection, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • COVID-19
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Respiratory Syncytial Virus (RSV)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Pneumonia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Tuberculosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Respiratory Vaccines Market, By Age Group, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Respiratory Vaccines Market, By Route of Administration, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Intranasal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Respiratory Vaccines Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Vaccination Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Government and Public Health Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Respiratory Vaccines Market, By Distribution Channel, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital and Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Government Suppliers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global Respiratory Vaccines Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Infection, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • GlaxoSmithKline plc
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca PLC
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Moderna, Inc.
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CSL Limited
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bharat Biotech International Limited
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novavax, Inc.
    • Company Highlights
    • Manufacturing Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us

*Browse 32 market data tables and 28 figures on ‘Respiratory Vaccines Market' - Global forecast to 2033